advertisement
Kojima S 9
Showing records 1 to 9 |
Display all abstracts from Kojima S117152 Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 studyTanihara H
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2579-2591
118231 Trabeculotomy Using the Kahook Dual Blade for Exfoliation Glaucoma and Primary Open Angle Glaucoma: Comparison of Outcomes According to Incision RangeIrie A; Nakashima KI
Journal of Glaucoma 2024; 33: 270-276
117152 Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 studyYamamoto T; Aihara M
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2579-2591
118231 Trabeculotomy Using the Kahook Dual Blade for Exfoliation Glaucoma and Primary Open Angle Glaucoma: Comparison of Outcomes According to Incision RangeInoue T
Journal of Glaucoma 2024; 33: 270-276
117152 Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 studyKoizumi N
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2579-2591
118231 Trabeculotomy Using the Kahook Dual Blade for Exfoliation Glaucoma and Primary Open Angle Glaucoma: Comparison of Outcomes According to Incision RangeKojima S
Journal of Glaucoma 2024; 33: 270-276
117152 Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 studyFukushima A
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2579-2591
118231 Trabeculotomy Using the Kahook Dual Blade for Exfoliation Glaucoma and Primary Open Angle Glaucoma: Comparison of Outcomes According to Incision RangeTakihara Y; Takahashi E
Journal of Glaucoma 2024; 33: 270-276
117152 Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 studyKawakita K; Kojima S; Nakamura T; Suganami H;
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 2579-2591
Issue 24-4
Change Issue
advertisement